Syncom Formulations (india) Share Price

ABOUT Syncom Formulations (india)

• Industry Biotechnology & Drugs
• ISIN INE312C01025
• BSE Code 524470
• NSE Code SYNCOMF

Syncom Formulations (India) Limited is an India-based company that is engaged in the pharmaceutical business. The Company is engaged in the development, manufacturing & sale of pharmaceutical products and services& trading of commodities and renting of properties. The Company manufactures and markets more than 200 pharmaceutical formulation products in various dosage forms, like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections and Dry Vial injections, Dry Syrups, Ointments and Inhalers. The Company's domestic division product categories include Cratus Life Care, Cratus Evolve and Cratus Right Nutrition. Its products include Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Ciprofloxacin Tablets USP 750 mg, Cefazolin For Injection USP 1 gm, Cefotaxime For Injection USP 1 gm, Ceftriaxone for Injection USP 500 mg, Albendazole Oral Suspension USP 100mg, Cetirizine Oral Solution BP, Clotrimazole Cream USP, Compound Benzoic Acid Ointment BP, and others.

MANAGEMENT

• Kedarmal Bankda Executive Chairman of the Board
• Ankit Bankda Chief Financial Officer
• Vaishali Agrawal Compliance Officer, Company Secretary
• Vijay Bankda Managing Director, Executive Director
• Rinki Bankda Whole-Time Director